Changqing Yang: Clinical Trials

3 trials sponsored by Changqing Yang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Changqing Yang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The vPPG-detecting Software Guided Management of Cirrhotic Portal Hypertension
PPG-detecting software, LSM and PLT count - Portal Hypertension, Cirrhosis, Liver
UnknownChangqing Yang2502021-03-032023-04-20
Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
Spironolactone and carvedilol, Carvedilol - Cirrhosis, Portal Hypertension
Phase 4CompletedChangqing Yang962018-01-012020-08-25
Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS
Carvedilol, 3D-vHPS, Routine endoscopic procedures - Portal Hypertension, Cirrhosis
Phase 4UnknownChangqing Yang1002015-01-012020-02-25

Conditions studied

Fibrosis (3)  ·  Hypertension, Portal (3)  ·  Liver Cirrhosis (1)

Interventions

Carvedilol (2)  ·  Combined Modality Therapy (1)  ·  Spironolactone (1)  ·  Therapeutics (1)

Countries

China (3)

Top investigators

Jing Li, M.D. (1)